alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.2**

** **

**WAMU ASSET ACCEPTANCE CORP.**

** **

**RESTATED OFFICER’S CERTIFICATE**

 

 

I, Thomas G. Lehmann, certify that:

1.         I have reviewed this report on Form 10–K and all reports on Form 10–D required to be filed in respect of the periodcovered by this report on Form 10–K of Washington Mutual Mortgage Pass-Through Certificates, WMALT Series 2006-AR10 Trust(the ‘‘Exchange Act periodic reports’’);

2.         Based on my knowledge, the Exchange Act periodic reports, taken as a whole, do not contain any untrue statement of a  materialfact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.         Based on my knowledge, all of the distribution, servicing and other information required to be provided under Form 10–D for theperiod covered by this report is included in the Exchange Act periodic reports;

4.         Based on my knowledge and the servicer compliance statements required in this report under Item 1123 of Regulation AB, and except asdisclosed in the Exchange Act periodic reports, the servicers have fulfilled their obligations under the servicing agreement(s) in all material respects; and

5.         All of the reports on assessment of compliance with servicing criteria for asset-backed securities and their related attestationreports on assessment of compliance with servicing criteria for asset-backed securities required to be included in this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules 13a–18 and 15d–18 have been included as an exhibit to thisreport, except as otherwise disclosed in this report.  Any material instances of noncompliance described in such reports have been disclosed in this report on Form 10–K. 

In giving the certifications above, I have reasonably relied on information provided to me by the following unaffiliated parties: None.

 

 

Date:  As of March 15,2007

|   |   | /s/ Thomas G. Lehmann                                                                        |
|--------|--------|----------------------------------------------------------------------------------------------|
|   |   | Name:  ThomasG. Lehmann                                                                 |
|   |   | Title:   President and Senior Officer in Charge of Securitization of the Depositor |
FAA-2011-0573

From Virgin America:

Dated 07/07/11

Hello Sanjay,

We have reviewed AD2011-13-11 in detail, and have a question on paragraph (m), 

requiring a "new" part to be installed if the repetive inspection requires replacement of 

the actuator. Does this indeed mean "newly manufactured"?

I couldn't find this requirement in either the EASA AD nor the Airbus AOT. I tried to see 

if the economic analysis would have this information, but only the federal register is 

loaded on the regulations.gov website, under Docket No. FAA-2011-0573.

Best Regards,

Krista Dial

Manager, Maintenance Programs and Reliability

555 Airport Blvd.

Burlingame, CA 94010

650-762-7168 phone

650-648-0537 fax
EXHIBIT 32

   CERTIFICATIONS OF JOSEPH R. ROZELLE, PRINCIPAL EXECUTIVE OFFICER AND
     PRINCIPAL FINANCIAL OFFICER, PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Annual Report on Form 10-K of Lunar Growth
Corporation (the "Company") for the period ended June 30, 2007, as
filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, the undersigned officer of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.  The Report fully complies with the requirements of section 13(a) of
the Securities Exchange Act of 1934; and

2.  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


Date:  October 15, 2007                  /s/ Joseph R. Rozelle
                                         --------------------------
                                         JOSEPH R. ROZELLE
                                         Principal Executive Officer
                                         and Principal Financial Officer


The foregoing certification is being furnished as an exhibit to the
Form 10-K pursuant to Item 601(b)(32) of Regulation S-K and Section 906
of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350,
Chapter 63 of Title 18, United States Code) and, accordingly, is not being
filed as part of the Form 10-K for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, and is not incorporated by reference
into any filings of the Company, whether made before or after the date
hereof, regardless of any general incorporation language in such filing.

A signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff
upon request.
##### 



EXHIBIT 31.1 CERTIFICATION PURSUANT TO RULE 13a-14(a) or RULE 15d-14(a),
AS ADOPTED PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002 I, Carl J. Johnson, President and Chief Executive Officer of Matrixx
Initiatives, Inc., certify that: 1.     I have reviewed this quarterly report on Form 10-Q of Matrixx Initiatives,
Inc.; 2.     Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report; 3.     Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report; 4.     The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:  (a)     designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared;(b)     evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of
the period covered by this report based on such evaluation; and(c)     disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants
most recent fiscal quarter (the registrants fourth quarter in the case
of an annual report) that has materially affected or is reasonably likely
to materially affect, the registrants internal control over financial
reporting; and 5.     The registrants other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of registrants board of
directors (or persons performing the equivalent functions):  (a)     all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and(b)     any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.Date: May 14, 2004 /s/ Carl J. JohnsonCarl J. JohnsonPresident and Chief Executive Officer
 28
EXHIBIT 32.1

PROTALIX BIOTHERAPEUTICS, INC.

CERTIFICATION

In connection with the quarterly report of Protalix BioTherapeutics, Inc.
		(the Company) on Form 10-Q for the period ended June 30, 2007 as
		filed with the Securities and Exchange Commission (the Report), I,
		David Aviezer, President and Chief Executive Officer of the Company, hereby
		certify as of the date hereof, solely for purposes of Title 18, Chapter 63,
		Section 1350 of the United States Code, that to the best of my knowledge:

(1) the Report fully complies with the requirements of Section 13(a)
		or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all
		material respects, the financial condition and results of operations of the
		Company at the dates and for the periods indicated.

This Certification has not been, and shall not be deemed,
		filed with the Securities and Exchange Commission.



|                                                              
|--------------------------------------------------------------
|                                                              
|Date: August 15, 2007                                         
|/s/ David Aviezer                                             
|                                                              
|David Aviezer, Ph.D.
			 President and Chief Executive Officer
Presidential Documents

Federal Register / Vol. 87, No. 52 / Thursday, March 17, 2022 / Presidential Documents 15027 

Memorandum of March 12, 2022 

Delegation of Authority Under Section 506(a)(1) of the Foreign Assistance Act of 1961 

Memorandum for the Secretary of State 

By the authority vested in me as President by the Constitution and the 

laws of the United States of America, including section 621 of the Foreign 

Assistance Act of 1961 (FAA), I hereby delegate to the Secretary of State 

the authority under section 506(a)(1) of the FAA to direct the drawdown 

of up to an aggregate value of $200 million in defense articles and services 

of the Department of Defense, and military education and training, to provide 

assistance to Ukraine and to make the determinations required under such 

section to direct such a drawdown. 

You are authorized and directed to publish this memorandum in the Federal 

Register. 

The White House, 

Washington, March 12, 2022 

[FR Doc. 2022–05774 

Filed 3–16–22; 8:45 am] 

Billing code 4710–10–P 


khammond on DSKJM1Z7X2PROD with PRESDOC2BIDEN.EPS</GPH>
III

104TH CONGRESS

1ST SESSION S. RES. 186

To authorize testimony by Senate employees and representation by Senate

Legal Counsel.

IN THE SENATE OF THE UNITED STATES

OCTOBER 19 (legislative day, OCTOBER 18), 1995

Mr. DOLE (for himself and Mr. DASCHLE) submitted the following resolution;

which was considered and agreed to

RESOLUTION

To authorize testimony by Senate employees and

representation by Senate Legal Counsel.

Whereas the defendant in Triangle MLP United Partnership v. United States, No. 95–430C, a civil action

pending in the United States Court of Federal

Claims, is seeking testimony at a deposition from

Charles Stek and Rebecca Wagner, employees of the

Senate who are on the staff of Senator Paul S. Sarbanes;

Whereas, by the privileges of the Senate of the United

States and rule XI of the Standing Rules of the Senate, no evidence under the control or in the possession of the Senate can, by administrative or judicial

process, be taken from such control or possession but

by permission of the Senate;
2

SRES 186 ATS

Whereas, when it appears that evidence under the control

or in the possession of the Senate is needed for the

promotion of justice, the Senate will take such action

as will promote the ends of justice consistent with

the privileges of the Senate;

Whereas, pursuant to sections 703(a) and 704(a)(2) of

the Ethics in Government Act of 1978, 2 U.S.C.

§§ 288b(a) and 288c(a)(2), the Senate may direct its

counsel to represent employees of the Senate with respect to subpoenas or requests for testimony issued

or made to them in their official capacities: Now,

therefore, be it

1 Resolved, That Charles Stek, Rebecca Wagner, and

2 any other employee of the Senate from whom testimony

3 may be required are authorized to testify and to produce

4 documents in the case of Triangle MLP United Partner5 ship v. United States, except concerning matters for which

6 a privilege should be asserted.

7 SEC. 2. That the Senate Legal Counsel is authorized

8 to represent Charles Stek, Rebecca Wagner, and any other

9 employee of the Senate in connection with the testimony

10 authorized by this resolution.

Æ
Exhibit 35.9



|     |  |  |                                            |                         
|---- |  |  | ------------------------------------------ | ------------------------
|LOGO |  |  |                                            | Corporate Trust Services
|     |  |  | MAC R1204-010                             
|     |  |  | 9062 Old Annapolis Road Columbia, MD
21045
|     |  |  | Tel: 410 884 2000                         
|     |  |  | Fax: 410 715 2380                         

Citibank, National Association

388 Greenwich Street

14th Floor

New York, New York 10013



|Re: | Annual Statement of Compliance for GS Mortgage Securities Corporation II, Commercial Mortgage Pass-Through Certificates, Series 2014-GC24
|--- | -----------------------------------------------------------------------------------------------------------------------------------------

Per the Pooling and Servicing Agreement dated as of September 1, 2014 (the Agreement), the undersigned, a duly authorized officer of Wells
Fargo Bank, N.A., as Certificate Administrator (Wells Fargo), hereby certifies as follows as of and for the year ending December 31, 2016 (the Reporting Period):

(a) A review of Wells Fargos activities during the Reporting Period and of its performance under the Agreement has been made under such
officers supervision; and

(b) To the best of such officers knowledge, based on such review, Wells Fargo has fulfilled all of
its obligations under the Agreement in all material respects throughout the Reporting Period.

March 1, 2017



|              
|--------------
|LOGO          
|BRIAN SMITH   
|Vice President



|                       |  |     
|---------------------- |  | ----
|Wells Fargo Bank, N.A. |  | LOGO
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHI N GTO N , DC 204 60

John V. Massinga le Greenwich Chemical Co n sul ting , Inc 3300 PGA Boulevard, Suite 635 Palm Beach Garden s, FL 33410 

## FEB
. 2014 OFFICE OF CHEMICAL SAFETY AND POLLUTION PREVENTION

Re: Toxic Substances Control Act Sec ti on 4 Test Ru le Requirements Dear Mr. Massingal e: This is in response to a letter-of

- intent-to-t est submitted by Greenwich Chemic al Consulting, Inc. , on behalf of Univar USA, Inc. , (U nivar ) for D

- erythro-hex-2-enonic acid, gamma.-lactone, monosodium salt (CASRN 6381-77-7) (Testing of Certain High Production Volume Chemicals,· Second Group ofChemicals, 76 FR 1067, January 7, 2011). The letter states that Univar wi ll sponsor physicaVchemical properties testing, environmental fate and path ways testing and aquati c toxic i ty testing in accordance with the tes t rul e . Accordi ngly , please submi t study plans and final reports to the U.S. Environmental Protection Agency (EPA) by April 15, 2014 , and February 11 , 20 1 5 , respectively. All subm is sions must be submitted electronically through EPA's Central Data Exchange (COX) portal. For information on the CDX portal, inc luding how to register and complete submissions please refe r to http :// www.epa.gov/opptintr / chemtestlereporting/index.html# web. If yo u have any questions, please contact J ohn Schaeffer by telephone at (202) 564-8173 or email at schaeffer.john @ epa.gov .

cc: Docket EPA-HQ-OPPT-2007-0531 Paul Lewi s, Ph.D. C hief Chem ical Information and

Testing B ranch

Internet Address 1 URL) • hltp //www epa gov Recycle d / R ecycla b le · Punted w1th Vegetable Oil Based Inks on 100% Postconsumer Process Chlorine Free Recycled Paper
<PAGE>



Exhibit 11 Computation of Per Share Earnings  

         Statement Regarding Computation of Earnings Per Share
                for the six months ended June 30, 1997
                             (Unaudited)


Assuming no dilution:
    Net income (in thousands)......................      $   865
                                                         -------
                                                         -------

    Weighted average number 
         of shares:

         Average shares outstanding:...............    2,454,765
         Average incremental shares related
              to stock options.....................       54,825
                                                          ------
                                                       2,509,590
                                                       ---------
                                                       ---------

    Income per share assuming no dilution:.........    $    0.34
                                                       ---------
                                                       ---------

Assuming full dilution:
    Net income (in thousands).....................     $     865
                                                       ---------
                                                       ---------
    Weighted average number
         of shares:

         Average shares issued....................     2,817,500
         Average incremental shares related
              to stock options....................        54,825
         Average treasury shares..................       (76,554)
                                                         -------
                                                       2,795,771
                                                       ---------
                                                       ---------
    Income per share assuming full dilution:......     $    0.31
                                                       ---------
                                                       ---------

Note:

    Earnings per share are computed based upon the weighted average common and
common equivalent shares outstanding for periods subsequent to the Company's
initial stock offering on May 1, 1996.  Accordingly, earnings per share for the
six months ended June 30, 1996 are not meaningful.
<partyblock><br><br><div align="center"><b><font size="+1">Compas Medical, P.C., as Assignee of YVAN PLETEAU, Appellant, <br><br>against<br><br>American Transit Ins. Co., Respondent.</font></b></div><br><br><p>Appeal from an order of the Civil Court of the City of New York, Queens County (Jodi Orlow, J.), entered June 18, 2013. The order denied plaintiff's motion for summary judgment and granted defendant's cross motion for summary judgment dismissing the complaint.</p><p>ORDERED that the order is modified by providing that defendant's cross motion for summary judgment dismissing the complaint is denied; as so modified, the order is affirmed, without costs. </p><p>In this action by a provider to recover assigned first-party no-fault benefits, plaintiff appeals from an order of the Civil Court which denied plaintiff's motion for summary judgment and granted defendant's cross motion for summary judgment dismissing the complaint. </p><p>Defendant's cross motion for summary judgment was predicated upon the defense that defendant had timely denied the claims at issue based upon plaintiff's assignor's failure to appear for duly scheduled examinations under oath (EUOs). In order to prove that the EUO letters had been timely mailed, defendant submitted two affidavits, each describing a portion of defendant's practices and procedures. While the affidavit that describes defendant's mail room practices and procedures alleges that defendant mailed EUO scheduling letters on October 1, 2010 and October 29, 2010, the other affidavit, which alleges, based upon a combination of personal knowledge and practices and procedures, that a scheduling letter was prepared for mailing on October 29, 2010, does not even mention the October 1, 2010 letter. Thus, defendant did not demonstrate its entitlement to summary judgment dismissing the complaint.</p><p>Plaintiff's contention that its motion for summary judgment should have been granted lacks merit. Plaintiff's moving papers failed to establish that the claims at issue had not been timely denied (<a href="../2015/2015_04787.htm" target="_blank"><i>see Viviane Etienne Med. Care, P.C. v Country-Wide Ins. Co.</i>, 25 NY3d 498</a> [2015]), or that defendant had issued timely denials of claim that were conclusory, vague or without merit as a matter of law (<a href="../2010/2010_08933.htm" target="_blank"><i>see Westchester Med. Ctr. v Nationwide Mut. Ins. Co.</i>, 78 AD3d 1168</a> [2010]; <a href="../2011/2011_51292.htm" target="_blank"><i>Ave T MPC Corp. v Auto One Ins. Co.</i>, 32 Misc 3d 128</a>[A], 2011 NY Slip Op 51292[U] [App Term, 2d Dept, 2d, 11th &amp; 13th Jud Dists 2011]). </p><p>Accordingly, the order is modified by providing that defendant's cross motion for summary judgment dismissing the complaint is denied.</p><p>Pesce, P.J., Aliotta and Solomon, JJ., concur.</p><br>Decision Date: September 19, 2016<br><br><div align="center"><form method="LINK" action="../../slipidx/at_2_idxtable.shtml"><input type="submit" value="Return to Decision List"></form></div></partyblock>